SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

HSBCs bearish assessment of CoreWeaves debt burden, financing costs and exposure to slower AI demand has fueled concern about the neocloud companys ability to fund growth. Traders are split between viewing the selloff as evidence of fundamental risk and buying the rebound while anticipating a short squeeze.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Middle East tensions and reported attacks on oil shipping and energy infrastructure have focused attention on crude supply-disruption risks, while speculation about US-Iran mediation has fueled sharp swings. Bulls point to potential supply constraints; bears argue that a deal or normalized shipping could unwind the risk premium and that the rally is overextended.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins rebound from recent lows has traders focused on whether it can clear nearby resistance and sustain a recovery. Bulls see breakout and short-squeeze potential, while skeptics call the move a false start and point to weak demand and broader macro risks.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to fresh lows is drawing attention as traders connect the stocks political-sentiment exposure to Trumps weakening approval and the approaching midterms, while also criticizing the companys limited revenue and crypto exposure. The conversation is broadly bearish, though some traders see the decline as setting up a short-term bounce.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A breakout to record highs ahead of Lillys Q3 earnings is driving attention, with traders citing strong obesity-drug demand and hoping for stronger guidance; some also point to European regulatory backing for Foundayo. The rally has drawn bullish momentum chatter, while others question whether the gains can hold or already reflect optimism.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a sharp neocloud and AI-infrastructure selloff as traders debate concerns about debt, funding costs, and whether projected AI demand will justify the sectors buildout. Bears expect further declines, while bulls call the stock oversold and point to managements financing comments and IRENs power and data-center assets as reasons for a rebound;

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

An intraday QQQ rebound was widely linked by traders to unconfirmed reports of a possible US-Iran deal and a pullback in oil prices. The community disputed the reports credibility and whether the move was sustainable or a bull trap, with elevated oil and tech-sector volatility adding to the uncertainty.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Unconfirmed reports of a possible U.S.-Iran deal dominated discussion around SPYs sharp rally, with traders linking the reports and a drop in oil to improved risk appetite. Some chased the move as peace news; others questioned the reports credibility and called the rally a potential trap or short-lived pump.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is drawing attention after a sharp semiconductor selloff and volatile rebound, as traders debate whether concerns about AI spending, debt and returns signal a deeper sector correction. Bulls point to ongoing chip demand and oversold conditions as reasons for a bounce, while bears warn that selling may continue.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is drawing attention after a sharp rebound alongside other meme coins, with traders cheering renewed momentum and accumulating on dips. Others remain cautious, citing choppy consolidation, resistance, and the risk that the bounce fades.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?

GKOS shares surge 36.8% in six months, fueled by strong sales, iDose TR and Epioxa expansion, higher guidance and promising clinical developments.

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom's strong margins, G7 15-day rollout and promising pipeline support its growth outlook, but factory ramp-up costs, forex and input-price pressures pose risks.

Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy

Glaukos reports positive Phase 4 results for its iDose TR therapy, demonstrating superior efficacy over standalone cataract surgery.read more...

Glaukos Strengthens Retinal Pipeline Through RevOpsis Licensing Deal

GKOS expands its retinal pipeline with a licensing deal for RO-104 and exclusive RevMod platform rights, even as shares decline 6.3% following the news.

Glaukos Reports Positive Phase 4 Results For IDose TR With Cataract Surgery

(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT...

Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose TR in Combination with Cataract Surgery

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced positive topline results from the Phase 4 prospective, randomized, controlled clinical...

Glaukos Advances Eye Care Portfolio with Three-Year Epioxa Trial Data and Licensing Deal

Glaukos reports positive three-year Epioxa study results and secures an exclusive license for RevOpsis retinal candidate RO-104.read more...

Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Biologic for Retinal Diseases

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced an exclusive license agreement with RevOpsis Therapeutics, Inc. to develop and...

Glaukos Announces Positive Three-Year Epioxa Results Demonstrating Durable Clinical Outcomes in Keratoconus

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating...

Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?

Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Glaukos Corporation

Why Glaukos Stock Jumped Over 20% After-Hours Today

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance.</li><li>Strong glaucoma product sales, particularly in the U.S., drove a 38% year-over-year rise in total revenue, while losses narrowed and margins improved.</li><li>Retail sentiment on Stocktwits turned bullish, with users calling Glaukos a “hidden gem” and noting the stock’s chart “looks good.”</li></ul>Glaukos Corp shares climbed 21% in after-hours trading on Wednesday after the eye-care company delivered a strong third quarter (Q3) and raised its revenue expectations for the year.<h2 class="st-heading-2">Record Quarter</h2>The company reported $133.5 million in revenue, up 38% from a year earlier, helped by booming demand for its glaucoma products. U.S. glaucoma sales surged 57% to $80.8 million, lifting total glaucoma revenue to a record $110.2 million.Profitability also improved. Glaukos posted a gross margin of 78% and a non-GAAP margin of 84%, while trimming its net loss to $16.2 million, or $0.28 per share, from $21.4 million, or $0.39 per share, a year ago.<h2 class="st-heading-2">Outlook</h2>The company lifted its 2025 revenue forecast to $490 million-$495 million, up from a previous range of $480 million-$486 million. It also offered an early look at 2026 guidance, projecting sales between $600 million and $620 million.Glaukos closed the quarter with $277.5 million in cash and investments and no debt, underscoring a strong financial footing as it continues to expand its ophthalmic portfolio.<h2 class="st-heading-2">Stocktwits Users Call Glaukos A ‘Hidden Gem’&nbsp;</h2>On Stocktwits, retail sentiment for Glaukos was ‘bullish’ amid ‘high’ message volume.One user called Glaukos a “hidden gem,” saying they hoped the stock would finally get the attention it deserves.&nbsp;<stembedurl>https://stocktwits.com/erkdg/message/634255035</stembedurl>Another noted that the company’s chart was “looking good,” reflecting optimism about the stock’s technical setup.<stembedurl>https://stocktwits.com/TaoistTrader/message/634169905</stembedurl><a href="https://stocktwits.com/symbol/GKOS">Glaukos’ stock</a> has declined 49% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Glaukos Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance.

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$173.72
Prev Close	$166.96
Open	$168.46
Dividend Yield	0.00%
50-Day Moving Average	$172.12
Beta	1.21
Avg. Volume	842,070.86
PE Ratio	-51.21

52-Week High	$191.62
52-Week Low	$73.16
Market Capitalization	$9.85B
EPS (Annual)	-$3.28
Price to Book	14.40
Revenue Per Employee	$463,840.95

Feed

News

Sentiment

Earnings

Fundamentals

Info

GKOS Fundamentals